摘要
目的:评估18F-FDG-PET/CT显像对可疑乳腺癌复发的诊断与治疗意义。方法:回顾性评估46名有乳腺癌病史且在首次确诊后存在肿瘤标志物增高的患者所做的47份18F-FDG-PET/CT显像结果。结果:30名(65%)患者证实肿瘤复发,16名(35%)患者没有显示肿瘤复发的证据。31名患者得到32份不正常的PET/CT显像结果,15名患者的PET/CT结果正常。灵敏度、特异性、准确度分别为90%、71%、83%。PET/CT结果影响了24(52%)名患者的治疗方案。结论:对伴随肿瘤标志物升高的乳腺癌患者,相对于CT对肿瘤复发的诊断来说,PET/CT显像具有更大的优势,导致大部分患者治疗措施改变。
Objiective:To evaluate the value of 18↑F-FDG-PET/CT for diagnosis and trentment in suspicious recurrence of breast cancer.Methods:Forty-seven consecutive FDG-PET/CT studies of 46 women with a history of breast cancer presented with elevated serum tumor markers after their initial diagnosis were retrospectively evaluated.Results:Thirty(65%) patients had tumor recurrence,and 16(35%) showed no further evidence of disease.Thirty-one patients had 32 abnormal PET/CT studies,and 15 patients had normal with an overall sensitivity,specificity, and accuracy of 90%,71%,and 83%,respectively.PET/CT had an impact on the management of 24(52%) patients.Conclusion:In patients with breast cancer and rising tumor markers,FDG-PET/CT had high performance indices and was superior to CT for diagnosis of tumor recurrence,which led to changes mostly in the subsequent clinical management of these patients.
出处
《现代肿瘤医学》
CAS
2012年第11期2276-2279,共4页
Journal of Modern Oncology
关键词
正电子发射断层摄影
18F-脱氧葡萄糖
乳腺癌
肿瘤标志物
positron emission computed tomography(PET)
fluorine-18 fluorodeoxyglucose
breast cancer
tumor markers